Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.76 is 50% above its 5-year average of -1.51, near the high end of its 5-year range (-2.72–-0.75).
12.14% above its 12-month average of -0.86.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): -0.20.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.76
EARNINGS PER SHARE (EPS) AVG TTM
-0.86
EARNINGS PER SHARE (EPS) AVG 3Y
-1.02
EARNINGS PER SHARE (EPS) AVG 5Y
-1.51
EARNINGS PER SHARE (EPS) AVG 10Y
-10.11
EARNINGS PER SHARE (EPS) AVG 15Y
-16.34
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+12.14%
CURRENT VS 3Y AVG
+25.31%
CURRENT VS 5Y AVG
+49.61%
CURRENT VS 10Y AVG
+92.48%
CURRENT VS 15Y AVG
+95.35%
CURRENT VS 20Y AVG
N/A
Rezolute, Inc.
Market Cap
$415.98M
Earnings Per Share (EPS)
-0.76
TTM Avg
-0.86
3Y Avg
-1.02
5Y Avg
-1.51
Market Cap
$416.27M
Earnings Per Share (EPS)
-2.27
TTM Avg
-2.08
3Y Avg
-0.07
5Y Avg
-5.01
Market Cap
$418.95M
Earnings Per Share (EPS)
-0.75
TTM Avg
-2.34
3Y Avg
-2.48
5Y Avg
-2.46
Market Cap
$419.87M
Earnings Per Share (EPS)
-0.84
TTM Avg
-3.40
3Y Avg
-3.01
5Y Avg
-2.22
Market Cap
$411.21M
Earnings Per Share (EPS)
-5.18
TTM Avg
-2.77
3Y Avg
-1.90
5Y Avg
-1.90
Market Cap
$411.00M
Earnings Per Share (EPS)
0.50
TTM Avg
0.08
3Y Avg
-0.25
5Y Avg
-0.31
Market Cap
$422.72M
Earnings Per Share (EPS)
-1.33
TTM Avg
-17.45
3Y Avg
-17.77
5Y Avg
-15.77
Market Cap
$422.86M
Earnings Per Share (EPS)
-4.57
TTM Avg
-3.99
3Y Avg
-6.52
5Y Avg
-18.52
Market Cap
$424.10M
Earnings Per Share (EPS)
-1.98
TTM Avg
-3.65
3Y Avg
-4.15
5Y Avg
-2.79
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rezolute, Inc. (RZLT) | $415.98M | -0.76 | -0.86 | -1.02 | -1.51 |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -2.27 | -2.08 | -0.07 | -5.01 |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | -0.75 | -2.34 | -2.48 | -2.46 |
| Prothena Corporation plc (PRTA)vs › | $419.87M | -0.84 | -3.40 | -3.01 | -2.22 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | -5.18 | -2.77 | -1.90 | -1.90 |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | 0.50 | 0.08 | -0.25 | -0.31 |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | -1.33 | -17.45 | -17.77 | -15.77 |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | -4.57 | -3.99 | -6.52 | -18.52 |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | -1.98 | -3.65 | -4.15 | -2.79 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | -4.63 | -6.16 | -6.16 | -6.16 |
Trailing EPS (TTM)
$-0.76
Forward EPS (Est.)
$-0.70
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -0.75 |
| 2025-06-30 | -0.98 |
| 2024-06-30 | -1.33 |
| 2023-06-30 | -1.01 |
| 2022-06-30 | -2.26 |
| 2021-06-30 | -2.72 |
| 2020-06-30 | -3.54 |
| 2019-06-30 | -17.11 |
| 2018-06-30 | -26.83 |
| 2017-06-30 | -24.55 |
| 2016-06-30 | -30.14 |
| 2015-06-30 | -27.12 |
| 2014-06-30 | -51.84 |
| 2013-06-30 | -54.21 |
| 2012-06-30 | -0.64 |
